Correlation Between Kura Oncology and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Kura Oncology and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Monte Rosa.
Diversification Opportunities for Kura Oncology and Monte Rosa
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kura and Monte is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Kura Oncology i.e., Kura Oncology and Monte Rosa go up and down completely randomly.
Pair Corralation between Kura Oncology and Monte Rosa
Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Monte Rosa. In addition to that, Kura Oncology is 1.74 times more volatile than Monte Rosa Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about -0.07 per unit of volatility. If you would invest 948.00 in Monte Rosa Therapeutics on August 29, 2024 and sell it today you would lose (88.00) from holding Monte Rosa Therapeutics or give up 9.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kura Oncology vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Kura Oncology |
| Monte Rosa Therapeutics |
Kura Oncology and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kura Oncology and Monte Rosa
The main advantage of trading using opposite Kura Oncology and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Kura Oncology vs. Eliem Therapeutics | Kura Oncology vs. Scpharmaceuticals | Kura Oncology vs. Milestone Pharmaceuticals | Kura Oncology vs. Seres Therapeutics |
| Monte Rosa vs. Eliem Therapeutics | Monte Rosa vs. Scpharmaceuticals | Monte Rosa vs. Milestone Pharmaceuticals | Monte Rosa vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |